Showing 1531-1540 of 2223 results for "".
- Bonti's Novel Neurotoxin Shows Promise in Early Study of Scar Reduction After Mohs Surgeryhttps://modernaesthetics.com/news/bontis-novel-neurotoxin-shows-promise-in-early-study-of-scar-reduction-after-mohs-surgery/2472052/Topline results from Bonti’s SHINE-1 Phase 2a clinical trial suggest that its novel neurotoxin is safe and likely effective for scar reduction following Mohs surgery. EB-001, the active ingredient in EB-001A, is a novel botulinum neurotoxin serotype E (BoNT/E) with a unique clinical
- FDA: Energy-Based Vaginal Rejuvenation May Cause Burns, Scarringhttps://modernaesthetics.com/news/fda-energy-based-vaginal-rejuvenation-may-cause-burns-scarring/2472053/The FDA is cracking down on the use energy-based devices to perform vaginal 'rejuvenation.' The use of such devices to perform vaginal "rejuvenation," cosmetic vaginal procedures, or non-surgical vaginal procedures to treat symptoms related to menopause, urinary incontin
- First Patients Treated in Pulse Biosciences' Sebaceous Hyperplasia Studyhttps://modernaesthetics.com/news/first-patients-treated-in-pulse-biosciences-sebaceous-hyperplasia-study/2472061/Pulse Biosciences, Inc. says the first patients have been treated in its multi-center study to evaluate the safety and efficacy of its Nano-Pulse Stimulation (NPS) technology for eliminating Sebaceous Hyperplasia (SH). SH is an unsightly benign skin lesion that typically appears on facial skin an
- Cutera Launches truSculpt iD, Personalized Body Sculptinghttps://modernaesthetics.com/news/cutera-launches-trusculpt-id-personalized-body-sculpting/2472065/Cutera, Inc. introduced truSculpt® iD, which the company describes as the next evolution in body sculpting with unique hands-free capability and the ability to treat a full abdomen in as little as 15 minutes. truSculpt® iD’s sleek design and comprehensive handpiece options give phys
- Xact Scores Best of Hot Topics at ASAPS 2018https://modernaesthetics.com/news/xact-scores-best-of-hot-topics-at-asaps-2018/2472078/Cypris Medical, Inc.’s Xact technology took home the “Best of Hot Topics” award at the American Society for Aesthetic Plastic Surgery (AS
- FDA Says No to Evolus' Botox Rivalhttps://modernaesthetics.com/news/fda-says-no-to-evolus-botox-rival/2472089/The U.S Food and Drug Administration did not approve DWP-450, Evolus Inc's rival product to Allergan Plc's Botox, due to chemistry and manufacturing issues. As a result, the company pushed its estimate for the launch of the drug to the spring of next year. Read more
- Early Botox May Improve Surgical Scarshttps://modernaesthetics.com/news/early-botox-may-improve-surgical-scars/2472124/Early injections of botulinum toxin A can improve the final appearance of surgical scars, according to a study in the March issue of Plastic
- Valentine's Day and Beyond: Lip Enhancement on the Risehttps://modernaesthetics.com/news/valentines-day-and-beyond-lip-enhancement-on-the-rise/2472133/The big talk after the recent Grammy Awards wasn’t Hillary Clinton’s cameo or Lady Gaga’s incredible performance, it was Kendall Jenner’s seriously plump pucker. The Twitterverse lit up with accusations about what the 22-year-old did or didn’t do to achieve s
- Body by BTL: New Campaign Showcases Breadth of BTL Aesthetics Offeringshttps://modernaesthetics.com/news/body-by-btl-new-campaign-showcases-breadth-of-btl-aesthetics-offerings/2472134/BTL Aesthetics is celebrating the brand's innovation with a first-of-its-kind campaign for the professional aesthetics industry emphasizing full body results. The Body by
- Jacob Chacko, MD Joins Bonti's Board of Directorshttps://modernaesthetics.com/news/jacob-chackomd-joins-bontis-board-of-directors/2472135/Jacob Chacko, MD has joined Bonti’s Board of Directors. Dr. Chacko has served as the Chief Financial Officer of Ignyta, Inc. since May 2014. At Ignyta, he leads multiple functions, including Finance, Accounting, Investor Relations, Comm